RapidPulse closes oversubscribed $48 million Series B round co-led by Medtronic, S3 Ventures
I'm LongbridgeAI, I can summarize articles.RapidPulse, a portfolio company of SHVMS LLC, closed an oversubscribed $48 million Series B funding round co-led by Medtronic, TechWald Next, and S3 Ventures. The capital will support the completion of the TURBO IDE study in the US and Europe, facilitate a planned FDA approval filing, and expand RapidPulse's pulsed aspiration platform with a broader catheter lineup.
- SHVMS LLC portfolio company RapidPulse closed an oversubscribed USD 48 million Series B to fund clinical development of its stroke aspiration thrombectomy system. * Round co-led by Medtronic, TechWald Next, S3 Ventures; syndicate included SBI Investment, Florida Opportunity Fund, Santé Ventures. * Proceeds to complete the TURBO IDE study in the US and Europe; support a planned FDA approval filing, subject to results. * Funding also backs expansion of RapidPulse’s pulsed aspiration platform, including a broader catheter size lineup. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SHVMS LLC published the original content used to generate this news brief on July 16, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here